Dennis Mulroy

Dennis Mulroy

Director of Finance/CFO at ANAPTYSBIO, INC.

Net worth: 21 709 $ as of 2024-03-30

69 year
Health Technology
Finance
Health Services

Profile

Dennis M.
Mulroy
is currently the Chief Financial Officer at AnaptysBio, Inc. He was previously the CEO, Chief Financial & Accounting Officer at La Jolla Pharmaceutical Co. from 2015 to 2020.
Prior to that, he was the Chief Financial Officer, Treasurer & Director at Tissue Repair Co. from 2006 to 2013, and the Chief Financial Officer at Aries Ventures, Inc. from 2005 to 2006.
He also held the position of Chief Financial Officer at Molecular Imaging Corp.
from 2004 to 2005 and at SeraCare Life Sciences, Inc. from 2001 to 2003.
Additionally, he was the Chief Financial Officer at Taxus Cardium Pharmaceuticals Group, Inc. from 2005 to 2015 and at Bioceutix, Inc. in 2001.
He received his undergraduate degree from the University of San Diego in 1978.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-29 964 ( 0.00% ) 21 709 $ 2024-03-30

Dennis Mulroy active positions

CompaniesPositionStart
ANAPTYSBIO, INC. Director of Finance/CFO 2020-07-14
All active positions of Dennis Mulroy

Former positions of Dennis Mulroy

CompaniesPositionEnd
LA JOLLA PHARMACEUTICAL COMPANY Chief Executive Officer 2020-05-30
GENE BIOTHERAPEUTICS, INC. Director of Finance/CFO 2015-04-02
Director of Finance/CFO 2013-01-01
Aries Ventures, Inc. Director of Finance/CFO 2006-01-22
Director of Finance/CFO 2005-11-03
See the detail of Dennis Mulroy's experience

Training of Dennis Mulroy

University of San Diego Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dennis Mulroy's experience

Connections

93

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ANAPTYSBIO, INC.

Health Technology

GENE BIOTHERAPEUTICS, INC.

Health Technology

Private companies7

Health Technology

Aries Ventures, Inc.

Finance

Health Services

Health Technology

Health Technology

Health Technology

Bioceutix, Inc.

See company connections